Pharmacology, Toxicology and Pharmaceutical Science
Effusion
95%
Blood-Brain Barrier
89%
P-Glycoprotein
69%
ABCG2
61%
Drug
59%
Pharmacokinetics
59%
Neoplasm
58%
Brain Tumor
55%
Glioblastoma
49%
Mouse
49%
Microdialysis
48%
Brain Metastasis
45%
Drug Delivery
24%
Melanoma
23%
Glioma
21%
Elacridar
18%
Rat
16%
Poloxamer
15%
Anticarcinogen
14%
Survival
14%
Microcarrier
14%
Abacavir
14%
Pharmacodynamics
13%
Erlotinib
12%
Mouse Model
12%
Protein
11%
Radiation
11%
Wild Type Mouse
11%
Sunitinib
11%
Sorafenib
11%
Temozolomide
11%
Clinical Trial
10%
Drug Development
10%
Rhodamine 123
10%
Probenecid
9%
Tumor Model
9%
Mammalian Target of Rapamycin Inhibitor
9%
Fluconazole
9%
Brain Cancer
9%
Pemetrexed
9%
Zidovudine
9%
Radiosensitizing Agent
9%
Phosphotransferase Inhibitor
9%
Cediranib
9%
Nucleoside
9%
Animal
9%
Toxicity
8%
Protein Tyrosine Kinase Inhibitor
8%
Fluorouracil
8%
Protein Inhibitor
8%
Medicine and Dentistry
Brain
100%
Blood Brain Barrier
55%
Brain Metastasis
52%
Glioblastoma
50%
Effusion
47%
Neoplasm
46%
Therapeutic Procedure
40%
Nodular Melanoma
33%
ABC Transporter Subfamily B
31%
Drug Delivery
31%
Obstetric Delivery
29%
Breast Cancer Resistance Protein
29%
Central Nervous System
22%
Patient
22%
Drug
21%
Chemotherapeutic Agent
21%
Xenograft
20%
Brain Tumor
17%
Phosphotransferase Inhibitor
14%
Development
13%
Combination Therapy
11%
Magnetic Resonance Imaging
10%
Pharmacokinetics
9%
Plasma
9%
Analysis
9%
Pemetrexed
9%
Epidermal Growth Factor Receptor
9%
Disease
9%
Erlotinib
8%
Survival
8%
Temozolomide
7%
In Vitro
7%
Vemurafenib
7%
Ganglioglioma
7%
Inpatient
6%
Glioma Cell
6%
Molecularly Targeted Therapy
6%
Sunitinib
6%
Sorafenib
6%
Radiation Therapy
6%
Protein Inhibitor
6%
Incidence
6%
Tumor Cell
6%
Drug Therapy
5%
Clearance
5%
Genetic Heterogeneity
5%
Assessment
5%
Cells
5%
Flank
5%
Anticarcinogen
5%
Biochemistry, Genetics and Molecular Biology
Blood Brain Barrier
57%
P-Glycoprotein
17%
Protein
16%
Mouse
15%
Multidrug Resistance Associated Protein
14%
Permeability
13%
Drug Distribution
13%
Antibody
10%
Development
9%
Survival
9%
Epidermal Growth Factor Receptor
9%
Cyclosporins
9%
Bovine
8%
Microdialysis
8%
Accuracy
7%
Pharmacokinetics
7%
Agmatine
7%
Knockout Mouse
7%
Brain Homogenate
6%
Nested Gene
6%
Dasatinib
6%
Clinical Trial
6%
Metabolite
5%
Contrast
5%
Kinesin
5%
Drive
5%
Sample
5%
Genetic Heterogeneity
5%
Dose
5%
Tandem Mass Spectrometry
5%
Wild Type
5%
Pharmacodynamics
5%
Messenger RNA
5%
Mouse Model
5%
Thermodynamics
5%
Comprehension
5%
ABCG2
5%
